IPO News: Filed S-1/A: Alector Launches 9.25mm Share IPO with $18.00 - $20.00 Marketing Range


Initial Filing Date: 01/07/19

Launch Date: 01/29/19  

Price Range: $18.00 - $20.00

Initial Shares Offered (mm): 9.3

Shares Offered (Pre-Shoe | mm): 9.3

Primary Shares (mm):      9.3

Secondary Shares (mm): 0.0

Amount Offered (@ Midpoint)(mm): $175.8

% Secondary:      0.0%

Shares Outstanding (mm): 68.4

Market Value at Midpoint (mm): $1,298.9

Offering as % of Market Value:    13.5%

Bookrunners:      MS | BAML | COWN | BARC        

Major Holders:   MRL Ventures | OrbiMed | Polaris Venture Partners | Dr. Arnon Rosenthal 

Industry: Healthcare

Description: Alector is a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders.

Note:     Emerging Growth Company

Launch Link: S-1/A